SPRAVATO® for MDD: A Breakthrough Treatment for Depression | Relief Mental Health
living with major depressive disorder or MDD can feel isolating and exhausting especially when traditional treatments haven’t brought relief yet new therapies offer hope and spado may be one of them spado is an FDA approved nasal spray specifically designed for those struggling with treatment resistant depression or depression accompanied by Suicidal Thoughts or actions unlike traditional anti-depressants that Target serotonin and norepinephrine spado Works differently by interacting with with nmda receptors in the brain this unique approach has shown promising results often within days rather than weeks administered in a clinical setting spado is taken twice weekly under supervision combined with an oral anti-depressant to enhance its impact clinical trials reveal a rapid mood stabilization easing depressive symptoms and helping reduce Suicidal Thoughts it has become a vital option for patients who’ve tried other anti-depressants without success while side effects may occur including dizziness or nausea they are generally short-lived the clinical team at relief mental health will closely monitor you during each session prioritizing your safety and comfort we understand that each person’s journey is different and we’re here to help you explore this Innovative pathway toward relief relief mental health offers more than treatment we offer the support and expertise you need to regain control of your mental health ready to discover if Prov motto could be the right step for you contact relief mental health today to schedule your consultation we’re committed to helping you find relief
Major depressive disorder (or clinical depression) might not have a cure yet. But that doesn’t mean you’re out of options. There are treatments that can help improve your symptoms and make a big difference in your daily life. SPRAVATO® is one such treatment.
SPRAVATO® is a nasal spray that contains esketamine, which is a type of ketamine. Ketamine has been used in medical settings for years. But SPRAVATO® is the first FDA-approved treatment specifically for treatment-resistant depression (TRD) or depressive symptoms in adults with major depressive disorder (MDD) accompanied by suicidal thoughts or actions.
Learn more about SPRAVATO® from our blog:
About Relief Mental Health:
Relief Mental Health aims to create a new standard of mental health care by offering a continuum of innovative therapeutic interventions and responding to evolving patient needs. By putting our patients’ needs first, Relief provides expedited and personalized care to those in need. We are committed to helping you find relief.
Visit our website: https://reliefmh.com/
Follow us on social media:
Facebook: https://www.facebook.com/reliefmentalhealth
LinkedIn: https://www.linkedin.com/company/relief-mh/
X: https://x.com/reliefmh
Instagram: https://www.instagram.com/reliefmentalhealth_/
TikTok: https://www.tiktok.com/@reliefmentalhealth
YouTube: https://www.youtube.com/@UCl3JrTC5ye13r6VF1-c8_yw